GenePlanet Presents its Innovative Health Platform at MEDICA 2018

GenePlanetGenePlanet, the Swiss-backed biotech company present in more than 30 countries worldwide, is attending MEDICA, the leading international trade fair for the medical sector that takes place in Düsseldorf, Germany, from 12-15 November. "Our participation at MEDICA represents a great opportunity to introduce our solutions to a highly-qualified audience. The most important asset people have is their health. We believe GenePlanet can greatly contribute to empowering them to take action to live a healthier lifestyle," commented Marko Bitenc, GenePlanet's CEO.

The company's key innovation is Health Intelligence (Hi!) - a health engagement platform integrating biological data (genetic predispositions, the current status of blood biomarkers and microbiome data) with information from smart devices and wearables to provide recommendations and action plans to improve one’s health and lifestyle.

By setting personal goals and challenges, the user will be able to monitor their progress in specific areas such as nutrition & diet, training & sports, skincare and mental well-being to facilitate long-term behavioural changes that lead to better overall health.

During the event, GenePlanet will also present its successful flagship product, NutriFit - one of the most important players in the field of Nutrigenomics and NutriSkin - a DNA test for personalised skincare and rejuvenation. The company will also show a non-invasive prenatal testing based on cell-free foetal DNA for detection of Down syndrome and other chromosomal abnormalities (NIPT); an accurate test for more than 600 genetic disorders for future parents (Carrier Screen); a test for 87 genetic disorders & 32 medications (Newborn Screen) and Cancer Screen for hereditary cancer risk assessment.

For further information, please visit:
https://geneplanet.com

About GenePlanet

GenePlanet is specialised in genetic testing and related advanced molecular techniques and recognised for offering personalised DNA analyses. By being R&D oriented, the company constantly strives for new discoveries that enables it to provide its clients with the latest and best products developed from its in-house research and development. GenePlanet was established in 2008 in Slovenia by Marko Bitenc, a Silicon Valley Singularity University alumnum, and has just been recognised as the Exporter of the Year 2018 by the public agency SPIRIT Slovenia.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...